Skip to main content
. 2022 Mar 9;9(3):1597–1607. doi: 10.1002/ehf2.13857

Figure 1.

Figure 1

Association between TAPSE/PASP ratio and the risk of all‐cause mortality among cardiac resynchronization therapy (CRT) recipients. The curve represents the hazard ratio change for all‐cause mortality with overlaid 95% confidence intervals (blue) across TAPSE/PASP ratio as a continuous variable before CRT implantation. PASP, pulmonary artery systolic pressure; TAPSE, tricuspid annular plane systolic excursion.